1. Home
  2. FANG vs EW Comparison

FANG vs EW Comparison

Compare FANG & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diamondback Energy Inc.

FANG

Diamondback Energy Inc.

N/A

Current Price

$185.23

Market Cap

56.8B

Sector

Energy

ML Signal

N/A

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

N/A

Current Price

$85.18

Market Cap

48.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FANG
EW
Founded
2007
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Industrial Specialties
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.8B
48.9B
IPO Year
2012
1999

Fundamental Metrics

Financial Performance
Metric
FANG
EW
Price
$185.23
$85.18
Analyst Decision
Strong Buy
Buy
Analyst Count
31
29
Target Price
★ $234.52
$100.96
AVG Volume (30 Days)
2.3M
★ 2.8M
Earning Date
11-02-2026
10-29-2026
Dividend Yield
★ 2.39%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 6.72
1.07
Revenue
★ $15,026,000,000.00
$6,067,600,000.00
Revenue This Year
$31.57
$11.40
Revenue Next Year
N/A
$9.90
P/E Ratio
★ $27.49
$80.95
Revenue Growth
★ 35.79
11.55
52 Week Low
$137.03
$72.30
52 Week High
$216.90
$96.29

Technical Indicators

Market Signals
Indicator
FANG
EW
Relative Strength Index (RSI) 38.32 45.23
Support Level $169.26 $83.49
Resistance Level $186.66 $89.41
Average True Range (ATR) 4.45 1.81
MACD -1.31 -0.02
Stochastic Oscillator 8.50 41.43

Price Performance

Historical Comparison
FANG
EW

About FANG Diamondback Energy Inc.

Diamondback is a crude oil and natural gas exploration and production firm whose operations represent a pure-play in the US Permian Basin. The company went public in 2012 and has established itself as a top-tier independent producer through disciplined acquisition and operational excellence. The company's most transformational transaction occurred in September 2024 with the completion of its $26 billion merger with Endeavor Energy Resources, which added around 470,000 net acres and doubled Diamondback's total acreage position. Diamondback boasts an enviable position in the Midland sub-basin, with some of the lowest unit costs among its Permian peers.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: